HealthIT.com
Menu

Every claim we hold, and how far we can stand behind it.

142 claims across 39 products. 28% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.

Evidence classClaimsConfirmedWhat it can support
Peer-reviewed study195Reviewed before publication; assess study quality, funding, conflicts, and relevance to your setting.
Regulatory filing40A statement made to a regulator, where being wrong has consequences.
Independent report329Reporting outside a vendor publication; assess underlying data, sponsorship, and conflicts separately.
Customer case43A real deployment, but selected and framed by someone with an interest.
Press release6322The vendor's own announcement. Useful for dates and facts, not for outcomes.
Vendor page201Marketing copy. Establishes what is claimed, never that it is true.

Showing 5 of 5 matching claims (142 in the full corpus) · 0% of this selection is confirmed · clear filters

  1. OpenEvidence, a tool that doctors and nurses have likened to ChatGPT for medicine, planned to announce a $200 million raise at a $6 billion valuation; the round was led by Google Ventures, with participation from Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, Bond, and Craft, and its number of clinical consultations per month has nearly doubled to 15 million since July.

    OpenEvidenceIndependent reportUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_13448bdf904435ba7eda
    Version
    1
    Workflow
    Clinical Evidence & Decision Support
    Dimension
    economic value
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://techcrunch.com/2025/10/20/openevidence-the-chatgpt-for-doctors-raises-200m-at-6b-valuation/
  2. Raised a $101M Series C in June 2025, led by IVP with participation from Andreessen Horowitz and Lightspeed.

    Tennr RaeIndependent reportUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_073cabae5c53705ac414
    Version
    2
    Workflow
    Enterprise AI & Agent Orchestration
    Dimension
    market durability
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://siliconangle.com/2025/06/18/ai-startup-tennr-raises-101m-revolutionize-patient-referrals/
  3. Nabla raised a $70M Series C in June 2025, bringing total funding to $120M, with proceeds going toward billing and coding capabilities in its ambient scribe

    Nabla CopilotIndependent reportUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_841b11cce4bdd2b95280
    Version
    1
    Workflow
    Ambient Clinical Documentation
    Dimension
    market durability
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://www.statnews.com/2025/06/17/nabla-raises-70-million-ambient-market-heats-up/
  4. Named to the Forbes AI 50 list (2025) as one of the highest-revenue private healthcare AI firms.

    AbridgeIndependent reportUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_1b191a1086a55aec59a0
    Version
    1
    Workflow
    Ambient Clinical Documentation
    Dimension
    general
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://www.forbes.com/lists/ai50/
  5. Freed sells its scribe directly to clinicians for $99/month; as of late February 2025, 17,000 clinicians used Freed in about 2 million patient visits per month

    Freed AI ScribeIndependent reportUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_35c559d75a8bfa18c406
    Version
    1
    Workflow
    Ambient Clinical Documentation
    Dimension
    deployment traction
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://www.cnbc.com/2025/03/05/freed-raises-30-million-led-by-sequoia-to-tackle-clinician-burnout.html
Know a source we are missing?

Checking feedback availability…

Open to everyone — no account needed. This is a non-PHI service: never include patient identifiers.

We cannot action an evidence claim without something to check.

Your message is privately delivered to the editorial team. How we handle your information.